Author Index


Arthritis & Rheumatism, Volume 63,
November 2011 Abstract Supplement

Abstracts of the American College of
Rheumatology/Association of Rheumatology Health Professionals
Annual Scientific Meeting
Chicago, Illinois November 4-9, 2011.

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

I

Iacobelli SergioClinical and Genetic Features of Autoinflammatory Syndromes in Hispanic Patients: The Chilean Experience.
Iagnocco AnnamariaApplication of Ultrasound to Treat to Target Management of Rheumatoid Arthritis - Multicentre International Observational Experience.
Iana AndreeaSubclinical Atherosclerosis In Inflammatory Rheumatic Diseases.
Iannaccone Christine K.The Performance of Matrix-Based Risk Models for Rapid Radiographic Progression in An Observational Cohort of Established Rheumatoid Arthritis Patients.
 The Relationship Between Time in Remission and Functional Status in Rheumatoid Arthritis.
Iannone FlorenzoGiant Cell Tumor of Synovial Sheath: Of Two Cases Treated with Intra-Articular Infiltration of Infliximab.
 Predictors, Features and Effects of First Biologic Switch in Rheumatoid Arthritis within GISEA register: Italian 10-Year Experience.
Iannuzzi Michael C.Genome-Wide Association Study of African Americans Implicates Multiple Lung and Inflammatory Disease-Associated Loci in Sarcoidosis Susceptibility.
Ibanez DominiqueHigh-Sensitivity C-Reactive Protein As An Independent Risk Factor for Coronary Artery Disease in Systemic Lupus Erythematosus.
 Time to Recovery From Proteinuria in Lupus Nephritis Patients Receiving Standard of Care Treatment.
 Development of Atherosclerotic Vascular Events in Systemic Lupus Erythematosus: How Important Are Race/Ethnicity and Geography?
 Do Active Lupus Patients Continue to Improve At 12 Months by Systemic Lupus Erythematous Disease Activity Index 2000 Responder Index 50 (SRI-50)?
 Do Race/Ethnicity and Geography Affect Outcomes in An Inception Cohort of Patients with Systemic Lupus Erythematosus Followed for at Least 5 Years?
 Retrospective Validation of the 3 Laboratory Organ Systems of Systemic Lupus Erythematosus Disease Activity Index-2000 (SLEDAI-2K) Responder Index (SRI-50) Over 10 Years.
 Frequency and Characteristics of Prolonged Remission in Systemic Lupus Erythematosus.
 Lupus Disease Activity Does Not Improve Significantly in One System and Worsen in Another System.
 Adjusted Framingham Risk Factor Scoring for Systemic Lupus Erythematosus.
 Treatment of Hypertension and Hypercholesterolemia Is Not Successful in the Majority of Patients with Systemic Lupus Erythematosus.
 Quality of Life Measures Are Not Associated and Have No Discriminative Validity in Lupus Patients for Different Levels of Disease Activity.
 Clinical Impact of Frequency of Visits in Systemic Lupus Erythematosus.
 Late Versus Early Development of Lupus Nephritis.
Ibarra-Sanchez Maria Deficient Ubiquitin Ligase Casitas B-Lineage Lymphoma b Expression and Abnormal Peripheral Tolerance in CD4 T Cells From Systemic Lupus Erythematosus Patients.
Ibba ValentinaEnhanced Expression of KIR3DL2 in Natural Killer and CD3/CD4 Positive T Cells of Ankylosing Spondylitis Patients Compared to HLA-B2705 or B2709 Healthy Subjects.
Ibba-Manneschi LidiaOverexpression of VEGF165b, An Inhibitory Splice Variant of Vascular Endothelial Growth Factor, Leads to Insufficient Angiogenesis In Patients with Systemic Sclerosis.
Ibrahim AliRadiographic Scoring Instruments Have High Specificity for Detecting Change in Axial Psoriatic Arthritis.
Ibrahim FowziaOne Year Randomised Controlled Trial of SEcond Line Agents in Myositis (SELAM): Late Additional immunosuppression is Ineffective in Patients Who Have Partially Responded to Steroids.
Ibrahim S.Improvement 3 to 12 Months Post Hip and Knee Replacement: Implications for Rehabilitation.
Ice John A.A Large-Scale, Multi-Racial Replication Study Identifies Novel Systemic Lupus Erythematosus Susceptibility Loci At IRF8, TMEM39A, and IKZF3/ZPBP2.
 Large-Scale, High-Density Genotyping Performed by the Sjgren's Genetics Network Using the ImmunoChip Identifies PRKRA as a Novel Sjgren's Syndrome Susceptibility Locus and Confirms Associations with IRF5, BLK and MHC.
 A High-Density Genome-Wide Association Study by the Sjgren's Genetics Network Identifies Five Novel Susceptibility Loci for Primary Sjgren's Syndrome and Confirms Association with MHC, IRF5, and BLK.
 Gene Expression Profiling in a Cohort of 275 European American Sjgren's Syndrome Patients and Controls.
 Triple X Syndrome (47,XXX) Increases the Risk and Accelerates the Onset of Systemic Lupus Erythematosus and Sjgren's Syndrome: Support for a Gene-Dose Effect From the X Chromosome.
Ichida HisaeUrinary Free Light Chain Concentration Is Associated with Disease Activity and Response to Treatment in Proliferative Lupus Nephritis.
 Notch Pathway Is Activated in Systemic Sclerosis (SSc).
 Ischemic Colitis (IC) Associated with Rheumatic Diseases; A Colonoscopic Study of 23 IC Cases.
 Classification of Two Subtypes in Adult-Onset Still's Disease.
 Anti-CADM-140 Antibody, Ferritin and IL-18 Are Associated with Disease Activity of Interstitial Lung Disease in Anti-CADM-140 Antibody-Positive Dermatomyositis.
 Atorvastatin Attenuates Skin Fibrosis Through the PI3K Pathway.
Ichinose KunihiroEvaluation of the Patients with Early Arthritis by 2010 RA Criteria in Conjunction with MRI of Wrists and Finger Joints.
Ida HiroakiEvaluation of the Patients with Early Arthritis by 2010 RA Criteria in Conjunction with MRI of Wrists and Finger Joints.
 Proteasome Disability Syndrome: An Analysis of the Pathogenesis of a New Autoinflammatory Syndrome, Nakajo-Nishimura Syndrome.
Ierna MichellePre-Clinical Bioimaging in a Mouse Model of Rheumatoid Arthritis.
Igarashi KazuhikoBach1 Regulates Osteoclastogenesis Via Heme Oxgenase-1 Dependent and Independent Pathways.
Igelmann ManfredPatients with Non-Radiographic Axial Spondyloarthritis Differ From Patients with Ankylosing Spondylitis in Several aspectsResults of a Cross-Sectional Cohort Study.
 The Degree of Spinal Inflammation Is Similar in Patients with Axial Spondyloarthritis Who Report High or Low Levels of Disease Activity a Cohort Study.
Iglesia Bruno Aspe-de laThe Lupus Damage Index Questionnaire and Its Correlation with the SLICC/ACR Damage Index and the LupusQoL in a Spanish Multicenter Lupus Cohort. Is It Really Measuring Damage?
Iglesias-Gamarra Antonio A.Are High Titers of Anti-CCP Antibodies in Psoriatic Arthritis Patients a Biomarker of Erosive Disease?
 The Protective Effect of Antimalarials On Thrombovascular Events In Latin American Systemic Lupus Erythematosus Patients.
Ihata AtsushiUltrasonography Is a Potent Tool for Prediction of Ongoing Joint Destruction During Clinical Remission of Rheumatoid Arthritis.
 Challenges to Expanding the Clinical Application of Musculoskeletal Ultrasonography Among Rheumatologists in Japan.
Iikuni NorikoLeptin Impinges on the Clearance of Autoimmune T Cells in Murine Lupus.
 Leptin Modulates Apoptosis of Autoimmune T Cells in Systemic Lupus Erythematosus.
Iizuka ManaOverexpression of T-Bet Gene Regulates Collagen Induced Arthritis Via IFN Independent Suppression of IL-6 Signal Transduction.
 Analysis of M3R Reactive T Cell Epitopes in M3R Induced Autoimmune sialoadenitis.
Ikari KatsunoriA Large-Scale Association Study Identified Multiple HLA-DRB1 Alleles Associated with Anti-Citrullinated Peptide Antibody Negative Rheumatoid Arthritis in Japanese.
 Identification of Clinical and Genetic Factors That Influence the Response to Methotrexate in Japanese Rheumatoid Arthritis Patients: Genome-Wide Association Study.
 Prognostic Factors for Surgical Intervention After Steroid Induced Avascular Necrosis of the Femoral Head.
Ikawa TakashiOne Year Efficacy and Safety Results of a Phase II Trial of Secukinumab in Patients with Rheumatoid Arthritis.
Ikeda KeiThe Impact of Ultrasonography on the Classification of Rheumatoid Arthritis with 2010 ACR/EULAR Criteria: Ultrasound-Combined Classification with Two Different Definitions of Gray-Scale Synovitis for Joint Involvement.
 Application of Ultrasound to Treat to Target Management of Rheumatoid Arthritis - Multicentre International Observational Experience.
Ikeda KeigoCharacterization of Anti Sjgren's Syndrome Nuclear Antigen-1 (SSNA-1) Novel Autoantibody in Patients with Primary Sjgren's Syndrome.
Ikeda TakaharuResponse to Hydroxychloroquine in Japanese Patients with Cutaneous Lupus Erythematosus Using the Cutaneous Lupus Erythematosus Disease Area and Severity Index.
Ikenoya KoheiNo Change in the Levels of PPD Reaction During Treatment with TNF Inhibitors in Rheumatoid Arthritis Patients in Japan, a Country with High Morbidity of Tuberculosis.
Ikeuchi HidekazuPro-Inflammatory Cytokine Measurement in Whole Blood Cultures Stimulated with Lipopolysaccharide Predicts Treatment Outcomes of Patients with Rheumatoid Arthritis Treated with Biologics.
Iking-Konert ChristofSensitivity to Change of the 7-Joint Ultrasound (US7) Score Among Patients with Different Musculoskeletal Diseases Under Twelve Months of Therapy.
Ikle DavidSerum Proteins Reflecting Inflammation, Injury, and Repair As Biomarkers of Disease Activity in ANCA-Associated Vasculitis.
 Immunoglobulin Concentrations and Infection Risk Among Patients with ANCA-Associated Vasculitis Treated with Rituximab or Cyclophosphamide.
 Extended Follow-up of Treatment with Rituximab Versus Cyclophosphamide for Remission-Induction of ANCA-Associated Vasculitis: Which Subsets Are At Greatest Risk for Flare?
Ilhan NevinSerum Galectin-3 Level in Patients with Scleroderma.
Illei Gabor G.Auto-Reactive IgEs and Basophils in Systemic Lupus Erythematosus.
 Functional Delivery of EBV-Mir-BART13 by exosomes in Human Salivary Gland Cells Affects Calcium Signaling.
 Triple X Syndrome (47,XXX) Increases the Risk and Accelerates the Onset of Systemic Lupus Erythematosus and Sjgren's Syndrome: Support for a Gene-Dose Effect From the X Chromosome.
 Sympathetic and Parasympathetic Abnormalities in Primary Sjgren's Syndrome (pSS) Patients Assessed in Outpatients Using Real-Time Digital Autonomic Nervous System (ANS) Monitoring.
 Deep Sequencing of Small RNAs Reveals Novel MicroRNAs in Minor Salivary Glands of Sjgren's Syndrome Patients.
 Large-Scale, High-Density Genotyping Performed by the Sjgren's Genetics Network Using the ImmunoChip Identifies PRKRA as a Novel Sjgren's Syndrome Susceptibility Locus and Confirms Associations with IRF5, BLK and MHC.
 Elevated IgE Anti-Ds-DNA Levels Are Associated with Serological Disease Activity in Patients with SLE: Potential for a New Treatment Target.
 The Majority of Micrornas in Serum and Saliva Is Concentrated in Exosomes.
 A High-Density Genome-Wide Association Study by the Sjgren's Genetics Network Identifies Five Novel Susceptibility Loci for Primary Sjgren's Syndrome and Confirms Association with MHC, IRF5, and BLK.
 Effect of Intravenous Cyclophosphamide Treatment on B Cells in SLE Nephritis.
 Urinary Exosomal Microrna-192 and -195 As Potential Biomarkers of Renal Disease Activity in Lupus Nephritis.
 Renal Mir-150 As Potential Biomarker of Chronicity in Lupus Nephritis.
Ilowite Norman T.Developing Consensus Treatment Plans for Proliferative Nephritis in Juvenile Systemic Lupus Erythematosus: Maintenance Therapy.
 The Childhood Arthritis & Rheumatology Research Alliance Network Registry: Demographics and Characteristics of the Initial One Year Cohort.
 Trial of Early Aggressive Therapy in Polyarticular Juvenile Idiopathic Arthritis.
 Development of Consensus Treatment Plans for New-Onset Systemic Juvenile Idiopathic Arthritis.
 CD146 Endothelial Progenitor Cell Number Increases Following 36 Months of Atorvastatin Therapy in Children and Adolescents with SLE: The Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Cohort.
 A Secondary Analysis of the Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Study Shows That Atorvastatin Therapy Reduces Progression of Carotid Intima Medial Thickening in Pubertal SLE Patients with Higher C Reactive Protein.
 Reduction of Annexin A5 Anticoagulant Activity in Children with Systemic Lupus Erythematosus.
Im Churl HyunInflammatory Burden Predicts Plaque Formation of Carotid Artery in Rheumatoid Arthritis.
IMACS and PRINTO Defining Clinically Relevant Changes in Core Set Activity Measures for Adult and Juvenile Idiopathic Inflammatory Myopathies (IIM).
Imagawa TomoyukiMycophenolate Mofetil (MMF) Versus Azathioprine As Maintenance Therapy Combined with Monthly Intravenous Cyclophsophamide (IVCY) in Juvenile Lupus Nephritis.
 Radiological Evaluation of Systemic Juvenile Idiopathic Arthritis Treated with Tocilizumab, An Anti-IL6 Receptor Monoclonal Antibody.
Imai ToshioChemerin Activates Fibroblast-Like Synoviocytes In Patients with Rheumatoid Arthritis.
Imamura EmikoAnti-Inflammatory Profile of AS2444697, A Novel Interleukin-1 Receptor-Associated Kinase-4 Inhibitor.
Imanaka HiroyukiCan Long-Term Use of Tocilizumab Induce Drug-Free Remission in Systemic Juvenile Idiopathic Arhtritis Refractory to Steroid Therapy?
 Measuring S100A12 and Vascular Endothelial Growth Factor Can Differentiate Familial Mediterranean Fever and Early Onset Sarcoidosis From Systemic Juvenile Idiopathic Arthritis.
Imanishi JunkoAnti-Inflammatory Profile of AS2444697, A Novel Interleukin-1 Receptor-Associated Kinase-4 Inhibitor.
Imazio M.Colchicine Halves, but Does Not Eliminate Recurrences in Pericarditis: Colchicine for Recurrent Pericarditis. A Randomized, Controlled Trial.
Imboden John B.Extra-Articular Manifestations of Rheumatoid Arthritis in An Ethnically Diverse Cohort: Prevalence and Clinical Associations.
 C-Reactive Protein Associated with Depression in Patients with Rheumatoid Arthritis.
Imbuka DorothyLarge Scale Analysis of Serum Tumor Necrosis Factor Alpha Levels in Systemic Lupus Erythematosus.
Imhof Beat A.Soluble Junctional Adhesion Molecule-B Inhibits Angiogenesis in Rheumatoid Arthritis.
Imhoff HeidiComparison of Disease Characteristics of rheumatoid arthritis patients in Remission According to the DAS Criteria Versus the New ACR/EULAR Criteria in a Real-World Patient Population.
Immermann F.Low Placebo Responses and Clinical Components of the Biomarkers of Lupus Disease (BOLD) Study May Provide Useful Insights for Systemic Lupus Erythematosus Clinical Trial Design.
Immermann Frederick W.Medication Impact on Gene Expression Patterns May Depend on Biologic Subgroups in the Biomarkers of Lupus Disease (BOLD) Study.
Impens Ann J.Spectrum of Muscle Disease in Scleroderma.
Imundo Lisa F.A Needs Assessment of Hospital for Special Surgery's Charla De Lupus/Lupus Chat Teen and Parent Support Group: Gaining a Community Perspective on Nutritional Health to Inform Implementation of a Nutrition Education Intervention.
 A Secondary Analysis of the Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Study Shows That Atorvastatin Therapy Reduces Progression of Carotid Intima Medial Thickening in Pubertal SLE Patients with Higher C Reactive Protein.
 CD146 Endothelial Progenitor Cell Number Increases Following 36 Months of Atorvastatin Therapy in Children and Adolescents with SLE: The Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Cohort.
 Performance of the Systemic Lupus Erythematosus Responder Index in Juvenile Systemic Lupus Erythematosus.
Inaba YutakaRadiological Evaluation of Systemic Juvenile Idiopathic Arthritis Treated with Tocilizumab, An Anti-IL6 Receptor Monoclonal Antibody.
Inada ShinichiNew Index to Assess the Improvement From the Worst Rheumatoid Arthritis Activity without Formal Joint Count.
Inal VedatFrequency of Pulmonary Arterial Hypertension Is Not Increased in Takayasu's Arteritis.
Inami HiroshiAnti-Inflammatory Profile of AS2444697, A Novel Interleukin-1 Receptor-Associated Kinase-4 Inhibitor.
Inamo KarineSerum IL-21 Is Increased and Associated with Higher Disease Activity and Higher Serum Levels of Markers of B-Cell Activation in Primary Sjgren's Syndrome.
Inanc MuratBiologics use in SLE in 23 Centers - Data from the International Registry for Biologics In SLE (IRBIS).
 Development and Validation of a New Clinical Prediction Rule for 5-Year Survival in Early Scleroderma, a EUSTAR Study.
 A Retrospective Analysis of Anti-TNF Treatment of 146 Ankylosing Spondylitis Patients According to Gender.
 Analysis of Risk Factors for Relapses and Chronic Renal Failure in Lupus Nephritis: Long Term Follow-up of Biopsy Proven 172 Patients Followed at a Single Center.
 Cluster Analysis of Autoantibodies in 852 Patients with Systemic Lupus Erythematosus From a Single Center: Four Main Clusters with Prognostic Implications.
Inanc NevsunA Mucocutaneous Activity Index for Behcet's Disease.
Ingegnoli FrancescaWatermelon Stomach in Systemic Sclerosis: A EUSTAR Case-Control Study.
Ingham MikePerceived Benefits of Intravenous Biologic Therapy Among Patients with Rheumatoid Arthritis.
 Improved Quality of Life and Productivity in Patients with Moderate or Severe Rheumatoid Arthritis Actively Switched to Treatment with Infliximab From Adalimumab or Etanercept Therapy.
Ingle James N.Musculoskeletal Inflammation and Estrogens: T-Cell Leukemia 1A (TCL1A) Gene-Dependent Regulation of Inflammatory Cytokines.
Inman R. D.Cost Per Placebo Adjusted Response of Golimumab, Adalimumab, and Etanercept in Patients with Active Ankylosing Spondylitis.
 Profiling NSAID Responders in Ankylosing Spondylitis.
 Increased T Cell Receptor Clonotype Sharing Among Ankylosing Spondylitis Patients Revealed by Deep Repertoire Sequence Analysis.
Inman Robert D.Binding of Killer Immunoglobulin Receptors 3DL1 and 3DL2 Is Associated with Surface Expression of Major Histocompatibility Complex Class I Free Heavy Chains and Human Leukocyte Antigen B27 Presenting Abnormal Peptides.
 Continuance of Non-Steroidal Anti-Inflammatory Drugs May Reduce Radiographic Progression in Ankylosing Spondylitis Patients on Biological Therapy.
 Sustained Clinical Response with Golimumab Administered Subcutaneously Every 4 Weeks in Ankylosing Spondylitis: 104-Week Results of a Randomized, Placebo-Controlled Study.
 Endoplasmic Reticulum Aminopeptidase 1 Interaction with Human Leukocyte Antigen B27 Influences the Unfolded Protein Response.
 Macrophage Polarization Plays the Defining Role in Intracellular Persistence and Clearance of Chlamydia.
 Nafamostat Mesylate, a Serine Protease Inhibitor, Demonstrates Novel Antimicrobial Properties and Anti-inflammatory Effects in Chlamydia-Induced Arthritis.
 Eotaxin: A Novel Biomarker in Ankylosing Spondylitis That Predicts Less Structural Damage.
 Evidence for a Link Between Inflammation and Radiographic Progression in Ankylosing Spondylitis.
 The Effect of Anti-Tumor Necrosis Factor Therapy with Two Different Doses of Golimumab on Radiographic Progression in Definite Ankylosing Spondylitis: 4-Year Results.
Inokuma ShigekoPostmarketing Surveillance of Tocilizumab for Rheumatoid Arthritis In JapanFull Analysis Report of 7,901 Patients.
Inoue AsukaIL-6 Overproduction Is Predominantly Related to Arthritis in TNF-Induced Adipose-Related Protein (TIARP) Deficient Mice.
Inoue EisukeNo Evidence of Increased Mortality in Rheumatoid Arthritis Patients Treated with Biologics: Results From a Multicenter Cohort in Japan.
 Risk Factors Associated with Incident Hip Fractures in 9,720 Japanese Patients with Rheumatoid Arthritis: A Prospective Observational Cohort Study.
 Successful Maintenance of Remission Defined by the New ACR/EULAR Criteria Leads to Better Functional Outcomes in Rheumatoid Arthritis in Daily Practice, Especially in Patients with Early RA, Based on the Institute of Rheumatology, Rheumatoid Arthritis (IORRA) Cohort.
 Discrepancy Between Boolean Remission and DAS28 Remission Is Dependent on the Differences in Number of Swollen Joints and Patient Global Assessment in Daily Practice, Based on the Institute of Rheumatology, Rheumatoid Arthritis (IORRA) Cohort.
Inoue MakotoClinical Characterization of Extensive Interstitial Lung Disease in Rheumatoid Arthritis Patients.
Inoue NagamuConsensus Statements for Management for Intestinal Behcet's Disease in Japan.
Inoue YasushiInduction of Regulatory B Cells in Healthy Individuals and Patients with Systemic Lupus Erythematosus.
Insalaco AntonellaImpact of MEFV Mutations in Caucasian Children with Periodic Fevers: Clinical Evidence for a Gain of Function Effect.
Intema FemkeProlonged Improvement of Clinical Status and Structural Cartilage Tissue Repair by Joint Distraction in Treatment of End-Stage Knee Osteoarthritis; The 2 Years Follow-up Data.
International Childhood Arthritis Genetics Consortium Major Histocompatibility Complex Class II Gene Cluster Harbors Systemic Juvenile Idiopathic Arthritis Susceptibility Locus.
International Scleroderma Group Identification of Major Histocompatibility Complex Class II Alleles Associated with Systemic Sclerosis Through Imputation Strategy.
Investigators CARRAnetSocioeconomic Status Is Associated with Disability in Pediatric Systemic Lupus Erythematosus.
 The Childhood Arthritis & Rheumatology Research Alliance Network Registry: Demographics and Characteristics of the Initial One Year Cohort.
Investigators CARRANetDescription of the Localized Scleroderma Subgroup of the CARRA net Registry.
 Enthesitis Is a Significant Predictor of Decreased Quality of Life, Function, and Arthritis-Specific Pain Across Juvenile Idiopathic Arthritis (JIA) Categories: Preliminary Analyses From the CARRAnet Registry.
 A Cross Sectional Study of Juvenile Idiopathic Arthritis in African American Children Compared with Non-Hispanic White Children in the Childhood Arthritis and Rheumatology Research Alliance Registry.
 Characteristics of Anti-Cyclic Citrullinated Peptide Antibody and/or Rheumatoid Factor Positive Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Alliance Registry.
Investigators CATCHPatients with Early Rheumatoid Arthritis Determined to Be Inadequate Responders After 12 Weeks May Still Have Substantial Improvement in Core Set Measures. Results from an Early Arthritis Cohort.
 Function (HAQ) and Disease Activity (DAS) Varies by Rheumatoid Factor (RF) Status in Early Inflammatory Arthritis (EIA) with Stronger Associations in RF Positive Patients: Results From the CATCH Cohort.
 Response to Second-Line DMARDs and TNFi in Seropositive and Seronegative Patients in Early and Late Rheumatoid Arthritis Are Not the Same: Results From the CATCH Cohort and a Large, Established Rheumatoid Arthritis Database.
 Patients with a Severe Clinical Disease Course Can Be Identified Using Cluster Analysis Results From a Canadian National Early Arthritis Cohort.
 Factors Affecting Glucocorticoid Use in Early Rheumatoid Arthritis. Results from an Early Arthritis Cohort.
Investigators EUVASOptimal Definition for the Duration of Sustained Remission in ANCA-Associated Vasculitis.
Investigators GLOWOsteoarthritis Is Related to An Increased Risk of Falls and Fractures: A Prospective Multinational Cohort Study (the GLOW study).
Investigators GOGOHeritability and Linkage of Radiographic Progression of Hip and Knee Osteoarthritis: Results From the Longitudinal Component of the Genetics of Generalized Osteoarthritis Study.
investigators KORONADo Patients with Elderly-Onset Rheumatoid Arthritis Have Severe Functional Disability?
 What Factors Affect Discordance Between Physicians and Patients in Assessments of Global Health in Rheumatoid Arthritis?
Investigators OAIAssociation of Candidate Single Nucleotide Polymorphisms with Radiographic Knee Osteoarthritis in African-Americans: Data From the Genetic Components of Knee Osteoarthritis Study.
Investigators PHAROSPulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma: Racial Differences in Systemic Sclerosis-Related Pulmonary Hypertension.
 Better Survival in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension Patients Enrolled in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry.
 Clinical and Hemodynamic Features of Scleroderma Patients with Pulmonary Venous Hypertension Versus Pulmonary Arterial Hypertension.
investigators SLICCElectrocardiographic Abnormalities in a Large Systemic Lupus Erythematosus Inception Cohort.
Ioannou YiannisNitrated Nucleosome Levels in Patients with Systemic Lupus Erythematosus Associations with Ethnicity and Autoantibody Status.
 Nitrated Nucleosome Levels in Patients with Systemic Lupus ErythematosusAssociations with Disease Activity.
 Profiling Sub-Types of Anti-2 Glycoprotein I and Anti-Domain I Antibodies May Distinguish Between Different Clinical Phenotypes of the Antiphospholipid Syndrome.
 Patterns of Immunoglobulin-G Glycosylation Distinguish Different Clinical Phenotypes of Antiphospholipid Antibody Positivity.
Iorga Serban R.Epidemiology of Systemic Sclerosis in a Large United States Managed Care Population.
 Epidemiology of Systemic Lupus Erythematosus in a Large United States Managed Care Population.
 Epidemiology of Idiopathic Inflammatory Myopathy in a Large United States Managed Care Population.
Ip Wing YukForefoot Plantar Pressure and Gait Characteristic of Patients with Early Rheumatoid Arthritis: A Case-Control Study.
Irvine JohnCathepsin S Activity Measurements in Tears As a Putative Marker of Sjgren's Syndrome.
Irwin Debra E.Association of Lumbar Spine Individual Radiographic Features with Serum C-Propeptide (sCPII) and Serum Collagen Neoepitope (sC2C) of Type II Collagen: The Johnston County Osteoarthritis Project.
Isaacs J.Anti-Interleukin 17A Monoclonal Antibody Secukinumab Reduces Signs and Symptoms of Psoriatic Arthritis in a 24-Week Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.
 Tofacitinib (CP-690,550) in Combination with Traditional Disease-Modifying Anti-Rheumatic Drugs: Phase 3 Study Patient-Reported Outcomes in Patients with Active Rheumatoid Arthritis and An Inadequate Response to Disease-Modifying Anti-Rheumatic Drugs.
Isaacs JohnInvestigation of the Relationship Between Patient-Centered Factors and Baseline Disease Activity (DAS28) in Rheumatoid Arthritis (RA).
Isaacs John D.A Transcriptional Profile Present in CD4 T-Cells of Patients with Undifferentiated Arthritis Predicts the Future Development of Seronegative Rheumatoid Arthritis and Implicates IL-6 in Disease Evolution.
 Effect of Tocilizumab on Hematologic Markers Implicates Interleukin-6 Signaling in the Anemia of Rheumatoid Arthritis.
Isakova TamaraHypophosphatemia Is Associated with Nephrogenic Systemic Fibrosis: A Case-Control Study.
Isayeva KseniyaEfficacy of Rituximab Retreatment in Refractory Systemic Juvenile Idiopathic Arthritis.
 Safety and Efficacy of Tocilizumab Treatment In Children with Systemic Juvenile Idiopathic Arthritis.
Isenberg D.A.The Substantial Negative Impact of Systemic Lupus Erythematosus on the Working Lives of Patients: Results of the Lupus European Online Survey.
Isenberg David A.Nitrated Nucleosome Levels in Patients with Systemic Lupus ErythematosusAssociations with Disease Activity.
 Anti-beta2 Glycoprotein I IgA in Systemic Lupus Erythematosus Versus Controls.
 Systematic Review and Meta-Analysis of the Association of Systemic Lupus Erythematosus and Malignancy.
 Lipid-Antigen Presentation by CD1d B Cells Is Essential for the Maintenance of Inkt Cells: Aberrant B Cells From Patients with Systemic Lupus Erythematosus Impair Inkt Cell Homeostasis.
 Genome-Wide Association Study of Dermatomyositis Reveals Shared Genetic Risk Factors with Other Autoimmune Diseases.
 Anti-C1q Antibody in Systemic Lupus Erythematosus.
 Prevalence of Direct Coombs Test in Systemic Lupus Erythematosus. Clinical and Immunologic Associations.
 One Year Randomised Controlled Trial of SEcond Line Agents in Myositis (SELAM): Late Additional immunosuppression is Ineffective in Patients Who Have Partially Responded to Steroids.
 Predictors of Seizures in Systemic Lupus Erythematosus.
 Longitudinal Assessment of SLE Disease Activity: BILAG-2004, SLEDAI-2000 or Both?
 The BILAG-2004 Systems Tallya Novel Way of Analysing the BILAG-2004 Scores.
 Biologics use in SLE in 23 Centers - Data from the International Registry for Biologics In SLE (IRBIS).
 A Prospective Study of Seizures in Systemic Lupus Erythematosus.
 Derivation and Validation of Systemic Lupus International Collaborating Clinics Classification Criteria for Systemic Lupus Erythematosus.
 Nitrated Nucleosome Levels in Patients with Systemic Lupus Erythematosus Associations with Ethnicity and Autoantibody Status.
 Profiling Sub-Types of Anti-2 Glycoprotein I and Anti-Domain I Antibodies May Distinguish Between Different Clinical Phenotypes of the Antiphospholipid Syndrome.
Ishida Maria A.Antimalarials: A Window of Opportunity to Improve the Influenza A/H1N1 Vaccine Response in Lupus Patients Under Immunosuppressive Agents.
 Influenza H1N1 Vaccination in Mixed Connective Tissue Disease: Effectiveness and Safety Independent of Disease or Therapy.
 Influenza A H1N1/2009 Vaccine in Rheumatic Disease Patients Under Anti-TNF Therapy: Safety and Response.
Ishigatsubo YoshiakiTreatment with Infliximab Is Effective and Safty in BD Patients with Uveitis.
 Consensus Statements for Management for Intestinal Behcet's Disease in Japan.
 Genome-Wide Analysis of Imputed Genotypes Identifies Chemokine Receptor-1 CCR1) As a Novel Candidate Risk Locus in Behet's Disease.
 Bach1 Regulates Osteoclastogenesis Via Heme Oxgenase-1 Dependent and Independent Pathways.
 Challenges to Expanding the Clinical Application of Musculoskeletal Ultrasonography Among Rheumatologists in Japan.
 Ultrasonography Is a Potent Tool for Prediction of Ongoing Joint Destruction During Clinical Remission of Rheumatoid Arthritis.
Ishiguro NaokiGolimumab, A Human Anti-TNF Monoclonal Antibody, Administered Subcutaneously Every Four Weeks As Monotherapy in Patients with Active Rheumatoid Arthritis Despite DMARD Therapy: 52-Week Results of Clinical, Radiographic and Pharmacokinetic Assessments.
 52-Week Results of Clinical, Radiographic and Pharmacokinetic Assessments: Golimumab, a Human Anti-TNF Monoclonal Antibody, Administered Subcutaneously Every Four Weeks in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy.
 Efficacy of Total Arthroplasty Combined with Anti-Tumor Necrosis Factor Agents on Systemic Disease Activity in Patients with Rheumatoid Arthritis.
 Early Aggressive Intervention for Rheumatoid Arthritis Increases Rate of Remission Defined Using a Boolean Approach in Clinical Practice with Tocilizumab.
 Efficacy and Safety of Certolizumab Pegol Plus Methotrexate in Japanese Rheumatoid Arthritis Patients with An Inadequate Response to Methotrexate.
 Efficacy and Safety of Certolizumab Pegol without Methotrexate Co-Administration in Japanese Patients with Active Rheumatoid Arthritis.
 No Evidence of Increased Mortality in Rheumatoid Arthritis Patients Treated with Biologics: Results From a Multicenter Cohort in Japan.
 Postmarketing Surveillance of Tocilizumab for Rheumatoid Arthritis In JapanFull Analysis Report of 7,901 Patients.
Ishii KatsushiHistological Analyses of Surgically Resected Synovial Tissues In Patients with Rheumatoid Arthritis Treated with/without Biological Agents.
Ishii TomonoriEfficacy Evaluation of Tocilizumab with the New ACR/EULAR Remission Criteria and DAS28-ESR.
 Retroviral Vector System Identified FLRT2 As a Novel Cell Surface Autoantigen Against Anti-Endothelial Cell Antibodies in Systemic Lupus Erythematosus.
Ishikawa HisatoEarly Aggressive Intervention for Rheumatoid Arthritis Increases Rate of Remission Defined Using a Boolean Approach in Clinical Practice with Tocilizumab.
Ishikawa TakeshiAnti-Inflammatory Profile of AS2444697, A Novel Interleukin-1 Receptor-Associated Kinase-4 Inhibitor.
Ishimori Mariko L.The Role of Pain and Depression in Self-Reported Fatigue/Energy in Systemic Lupus Erythematosus.
 Altered Soluble Mediators of Inflammation At Baseline in Individuals Who Subsequently Transition to Systemic Lupus Erythematosus: Early Studies From the Lupus Autoimmunity in Relatives (LAUREL) Study.
Isidor BertrandA Novel Mutation in the PSTPIP1 Gene is Associated with An Autoinflammatory Disease Distinct From Classical Pyogenic Arthritis, Pyoderma Gangrenosum and Acne Syndrome.
Isik AhmetSerum Galectin-3 Level in Patients with Scleroderma.
 Pemetrexed Ameliorates Experimental Arthritis in Rats.
 Gemcitabine Ameliorates Experimental Arthritis in Rats.
 Preventive and Therapeutic Effects of Epigallocatechin-3-Gallate (EGCG) on Collagen-Induced Arthritis in Rats.
 Lapatinib Ameliorates Experimental Arthritis in Rats.
Isnard RichardSpectrum of Cardiac Lesions in Behet's Disease.
Isnardi IsabellePTPN22 Risk Allele Interferes with the Removal of Developing Autoreactive B Cells in Humans.
Isozaki TakeoDifferential Regulation of Serum Cytokine Profiles In Patients with Rheumatoid Arthritis Treated with Tocilizumab: Possible Involvement of Macrophage Migration Inhibitory Factor.
 A Novel Role for Monosodium Urate Monohydrate Crystals and Gouty Synovial Fluids in Monocyte Migration in Gout.
 Evidence for CXCL16 As An Endothelial Progenitor Cell Chemotactic Factor.
 A Disintegrin and Metalloprotease 10 (ADAM10) Is Overexpressed in Rheumatoid Arthritis Synovial Tissue and Mediates Angiogenesis.
 Anti-CCP Titers Are Predictive of the Response to Biological Agents in Patients with Rheumatoid Arthritis.
Israelsson LenaThe Complexity of Anti-CCP Positive Rheumatoid Arthritis, in the Context of Gene-Environment Associations.
 Analysis of Twin Concordance for ACPA Positivity and ACPA fine specificities in a Large Swedish Twin Cohort (TwinGene).
Issuree PriyaDeficiency of TACE in Myeloid Cells Prevents Arthritis in Mice.
Itami YukaPlasma Talin Is a New Diagnostic and Monitoring Marker for Rheumatoid Arthritis.
Ito Hiroyuki5-HT2C Receptor Agonists Attenuate Muscle Pain in a Rat Model of Fibromyalgia.
Ito TomonoriAnti-Inflammatory Profile of AS2444697, A Novel Interleukin-1 Receptor-Associated Kinase-4 Inhibitor.
Iudici MichelePrevention of Digital Ulcers in Systemic Sclerosis Patients: A Proposal of Risk Chart.
Ivanco DanaLong-Term Follow-up of Limited Cutaneous Systemic Sclerosis Patients with Anti-Th/to Antibody.
 The Significance of Tendon Friction Rubs in Early Diffuse Systemic Sclerosis Patients.
Ivashkiv Lionel B.Opposing Regulation of IFN Response Genes and STAT1 in Rheumatoid Arthritis Synovial Fluid Macrophages by TNF and the Synovial Fluid Microenvironment.
Iversen Line V.FLOW Cytometric Analysis of Circulating Microparticles In Systemic Sclerosis.
 Proteomic Characterization of Plasma Microparticles in Autoimmune Diseases.
 High Plasma Microparticle-IgG Burden Characterizes Systemic Lupus Erythematosus Patients and Is Associated with Autoantibodies Against DNA and C1q and Activation of the Complement System.
Iversen2 Maura D.Primary Care Physicians' Attitudes towards Managing Rheumatoid Arthritis: Room for Improvement.
Ivorra J. A. RománExtended Safety Observations From Denosumab Administration in Postmenopausal Women From the FREEDOM and FREEDOM Extension Trials.
Ivorra José Andrés RománComparison of Tocilizumab As Monotherapy or with Add-on Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis and An Inadequate Response to Previous Treatments.
Iwahashi MitsuyoshiSNP Algorithms for Prediction of Efficacy and Adverse Events of Abatacept.
 Validation of Algorithms Using Genome-Wide SNP Analysis for Prediction of Remission Criteria for Infliximab or Etanercept-Treated Rheumatoid Arthritis Patients Using Multiple Medical Cohorts.
 T-Cell-Related Cytokines Are Inhibited in Response to Tocilizumab in Patients with Rheumatoid Arthritis in Contrast with TNF-Inhibitor.
Iwai KoichiEfficacy and Safety of Certolizumab Pegol without Methotrexate Co-Administration in Japanese Patients with Active Rheumatoid Arthritis.
Iwai TakaoCelecoxib, a Selective Cyclooxygenase-2 Inhibitor, Improves a Bone Resorption Marker in Postmenopausal Women with Rheumatoid Arthritis.
Iwamoto MasahiroNo Change in the Levels of PPD Reaction During Treatment with TNF Inhibitors in Rheumatoid Arthritis Patients in Japan, a Country with High Morbidity of Tuberculosis.
Iwamoto NaokiEvaluation of the Patients with Early Arthritis by 2010 RA Criteria in Conjunction with MRI of Wrists and Finger Joints.
 Downregulation of Mir-193b in Systemic Sclerosis Regulates the Proliferative Vasculopathy by Urokinase-Type Plasminogen Activator Expression.
 Anti-Fibrotic Effects of Microrna-145 in Systemic Sclerosis Via a Multi-Step Regulation of TGF-Beta/CTGF Signaling.
Iwamoto TaroThe Impact of Ultrasonography on the Classification of Rheumatoid Arthritis with 2010 ACR/EULAR Criteria: Ultrasound-Combined Classification with Two Different Definitions of Gray-Scale Synovitis for Joint Involvement.
Iwamoto YukihideClinical Features of Pustulotic Arthro-Osteitis.
Iwaoka HarunaAnti-Inflammatory Profile of AS2444697, A Novel Interleukin-1 Receptor-Associated Kinase-4 Inhibitor.
Iwata SatoshiA New Derivative of Roxithromycin Modulates Immunological Responses and Ameliorates Collagen-Induced Arthritis.
Iwata ShigeruTofacitinib Reduces Interferon- and Interleukin-17 Production From CD4 T Cells in Patients with Rheumatoid Arthritis.
Izac BrigitteFamily-Based Association Study of SPA3, a New Susceptibility Locus for Spondyloarthritis on 6p11-q11.
Izmirly Peter M.Vascular Biomarkers and Risk of Treatment Failure in the Maintenance Phase of a Randomized Multicenter Trial Comparing Mycophenalate Mofetil and Azathioprine for Lupus Nephritis.
 Members of the Receptor for Advanced Glycation Endproducts Axis Associate with Systemic Lupus Erythematosus, and May Serve As a Brake to Disease Activity.
 A Distinctive Oral Microbiome Characterizes Periodontitis in Patients with Early Rheumatoid Arthritis.
Izquierdo ElenaThymic Stromal Lymphopoietin (TSLP) Is Overexpressed in Scleroderma Skin and It Is Induced by TLR3 Activation in Dermal Fibroblasts.
 Topical Vitamin D Analogue Calcipotriol Superinduces TSLP and IL-13 Expression in the Bleomycin Scleroderma Model but Does Not Modify Fibrosis.
 Transcriptome Analysis Reveals a Robust Profile In Osteoarthritis Synovial Fibroblasts.
Izumihara TomomaroValidation of Algorithms Using Genome-Wide SNP Analysis for Prediction of Remission Criteria for Infliximab or Etanercept-Treated Rheumatoid Arthritis Patients Using Multiple Medical Cohorts.
 Using Genome-wide Single Nucleotide Polymorphism Analysis to Investigate the Possibility of the CYB5R Gene Promoting Interstitial Pneumonia in Rheumatoid Arthritis Patients.
Izumikawa MiharuFluorine-18 Fluorodeoxyglucose Positron Emission Tomography Is Useful for the Visualization of Reticulo-Endotheliao System and Prediction of Steroid-Resistant Cases in Adult Onset of Still's Disease.
Abstract Supplement

Meeting Menu

2011 ACR/ARHP